Abstract:Type I interferons (IFNs) play essential roles in establishing and modulating host defense against microbial infection via induction of IFN-stimulated genes (ISGs) through Janus kinase (JAK)–signal transducer and activator of transcription (STAT) signaling pathway. However, dysregulation of IFNs production and function could also mediate immune pathogenesis such as inflammatory autoimmune diseases and infectious diseases via aberrantly activating inflammatory responses or improperly suppressing microbial controls. Thus, IFN responses need to be tightly regulated to achieve protective immunity against microbial infection while avoiding harmful toxicity caused by improper or prolonged IFN signaling. Multiple levels of cellular and molecular events act in a cooperated manner to regulate IFN responses, in especial, post-translational modification (PTMs) of signaling molecules and epigenetic modification of gene expression programs are two important mechanisms for regulation of IFN signaling and thus critical for orchestrating IFN-mediated host immune response to the complex pathogenic or environmental stimuli. Conventional PTMs such as phosphorylation and polyubiquitylation, as well as numerous other PTMs including acetylation, ISGylation, SUMOylation and methylation have been shown to potently modulate type I IFN signaling transduction via targeting distinct signaling steps or components. Moreover, epigenetic mechanisms, such as histone modification, DNA methylation, non-coding RNAs play critical roles in regulating chromatin structure and function, leading to flexible and dynamic gene expression patterns downstream type I IFN signaling. Herein, we summarize the recent advances in the PTMs and epigenetic mechanisms in regulation of type I IFN signaling and responses. The involvement of dysregulated IFN signaling in inflammatory and autoimmune diseases are also discussed.

Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils

Regulation of type I interferon signaling in immunity and inflammation: A comprehensive review

Noncanonical NF-κB Pathway Controls the Production of Type I Interferons in Antiviral Innate Immunity

Type I interferon and bacterial infection]

Type Ⅰ interferon and bacterial infection

Regulation of antiviral T cell responses by type I interferons

The Dual Nature of Type I and Type II Interferons

Human Type I Interferon Antiviral Effects in Respiratory and Reemerging Viral Infections

Type I interferons in infectious disease

Regulation of host/pathogen interactions in the gastrointestinal tract by type I and III interferons

Protective versus Pathogenic Type I Interferon Responses during Virus Infections

Regulation of type I and type III interferon induction in response to pathogen sensing

The Interplay Between Coronavirus and Type I IFN Response

Intracellular innate immunity and mechanism of action of cytosolic nucleic acid receptor‐mediated type I IFN against viruses

A Commentary of “type I Interferon Deficiency Can Lead to Severe COVID-19” in 10 Remarkable Discoveries from 2020 in Nature

Type I Interferon Protects Antiviral CD8+ T Cells from NK Cell Cytotoxicity

Type I and type III interferons: From basic biology and genetics to clinical development for COVID-19 and beyond

Regulation of virus-triggered type I interferon signaling by cellular and viral proteins

Viral pathogen-induced mechanisms to antagonize mammalian interferon (IFN) signaling pathway

Interplay between Janus Kinase/Signal Transducer and Activator of Transcription Signaling Activated by Type I Interferons and Viral Antagonism

An Emerging Role for Type I Interferons as Critical Regulators of Blood Coagulation